Agios proposes follow-on

Agios Pharmaceuticals Inc. (NASDAQ:AGIO), Cambridge, Mass. Business: Cancer Date announced: 4/10/14 Type: Follow-on To be raised: Up to $75 million Shares: TBD Price prior: $48.42 Underwriters: JPMorg...